About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2011 (2011), Article ID 473964, 14 pages
http://dx.doi.org/10.1155/2011/473964
Review Article

Morphological and Molecular Alterations in 1,2 Dimethylhydrazine and Azoxymethane Induced Colon Carcinogenesis in Rats

Institute of Pathology, Medical Experimental Centre, Medical Faculty, University of Ljubljana, Korytkova 2, 1105 Ljubljana, Slovenia

Received 14 September 2010; Revised 30 October 2010; Accepted 29 November 2010

Academic Editor: Andrea Vecchione

Copyright © 2011 Martina Perše and Anton Cerar. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Parkin, F. Bray, J. Ferlay, and P. Pisani, “Global cancer statistics, 2002,” CA Cancer Journal for Clinicians, vol. 55, no. 2, pp. 74–108, 2005. View at Scopus
  2. Y. S. Kim and J. A. Milner, “Dietary modulation of colon cancer risk,” Journal of Nutrition, vol. 137, no. 11, pp. S2576–S2579, 2007. View at Scopus
  3. A. E. Tammariello and J. A. Milner, “Mouse models for unraveling the importance of diet in colon cancer prevention,” Journal of Nutritional Biochemistry, vol. 21, no. 2, pp. 77–88, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. D. E. Corpet and F. Pierre, “How good are rodent models of carcinogenesis in predicting efficacy in humans? A systematic review and meta-analysis of colon chemoprevention in rats, mice and men,” European Journal of Cancer, vol. 41, no. 13, pp. 1911–1922, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. M. J. Wargovich, A. Jimenez, and A. Jimenez, “Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression,” Carcinogenesis, vol. 21, no. 6, pp. 1149–1155, 2000. View at Scopus
  6. J. Heyer, K. Yang, M. Lipkin, W. Edelmann, and R. Kucherlapati, “Mouse models for colorectal cancer,” Oncogene, vol. 18, no. 38, pp. 5325–5333, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. A. M. Femia and G. Caderni, “Rodent models of colon carcinogenesis for the study of chemopreventive activity of natural products,” Planta Medica, vol. 74, no. 13, pp. 1602–1607, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. M. Perše and A. Cerar, “The dimethylhydrazine induced colorectal tumours in rat—experimental colorectal carcinogenesis,” Radiology and Oncology, vol. 39, no. 1, pp. 61–87, 2005. View at Scopus
  9. R. P. Bird, “Aberrant crypt foci system to study cancer preventive agents in the colon,” in Methods in Molecular Medicine: Tumor Marker Protocols, M. Hanausek and Z. Walaszek, Eds., pp. 465–474, Humana Press, Totowa, NJ, USA, 1998.
  10. H. Nakagama, M. Ochiai, T. Ubagai, R. Tajima, K. Fujiwara, T. Sugimura, and M. Nagao, “A rat colon cancer model induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, PhIP,” Mutation Research, vol. 506-507, pp. 137–144, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Banerjee and P. Quirke, “Experimental models of colorectal cancer,” Diseases of the Colon and Rectum, vol. 41, no. 4, pp. 490–505, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. D. W. Rosenberg, C. Giardina, and T. Tanaka, “Mouse models for the study of colon carcinogenesis,” Carcinogenesis, vol. 30, no. 2, pp. 183–196, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. J. Chen and XU. F. Huang, “The signal pathways in azoxymethane-induced colon cancer and preventive implications,” Cancer Biology & Therapy, vol. 8, no. 14, pp. 1313–1317, 2009. View at Scopus
  14. M. Takahashi and K. Wakabayashi, “Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents,” Cancer Science, vol. 95, no. 6, pp. 475–480, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. E. S. Fiala and C. Stathopoulos, “Metabolism of methylazoxymethanol acetate in the F344 rat and strain-2 guinea pig and its inhibition by pyrazole and disulfiram,” Journal of Cancer Research and Clinical Oncology, vol. 108, no. 1, pp. 129–134, 1984. View at Scopus
  16. H. P. Glauert and M. R. Bennink, “Metabolism of 1,2-dimethylhydrazine by cultured rat colon epithelial cells,” Nutrition and Cancer, vol. 5, no. 2, pp. 78–86, 1983. View at Scopus
  17. C. T. Oravec, C. A. Jones, and E. Huberman, “Activation of the colon carcinogen 1,2-dimethylhydrazine in a rat colon cell-mediated mutagenesis assay,” Cancer Research, vol. 46, no. 10, pp. 5068–5071, 1986. View at Scopus
  18. W. W. L. Chang, “Histogenesis of colon cancer in experimental animals,” Scandinavian Journal of Gastroenterology, vol. 19, supplement, pp. 27–43, 1984. View at Scopus
  19. T. Shirai, J. Nakanowatari, and Y. Kurata, “Different dose-response relationships in the induction of different types of colonic tumors in wistar rats by 1,2-dimethylhydrazine,” Gann, The Japanese Journal of Cancer Research, vol. 74, no. 1, pp. 21–27, 1983. View at Scopus
  20. Z. Večerić and A. Cerar, “Comparison of Wistar vs. Fischer rat in the incidence of 1,2-dimethylhydrazine induced intestinal tumors,” Radiology and Oncology, vol. 38, no. 3, pp. 227–247, 2004. View at Scopus
  21. L. Breskvar and A. Cerar, “A role of gender in the occurrence of dimethylhydrazine induced colorectal tumors in Wistar rats,” Radiology and Oncology, vol. 31, no. 4, pp. 374–379, 1997. View at Scopus
  22. T. F. McMahon, J. O. Peggins, M. M. Centra, and M. Weiner, “Age-related changes in biotransformation of azoxymethane and methylazoxymethanol in vitro,” Xenobiotica, vol. 20, no. 5, pp. 501–513, 1990. View at Scopus
  23. B. A. Magnuson, E. H. South, J. H. Exon, R. H. Dashwood, M. Xu, K. Hendrix, and S. Hubele, “Increased susceptibility of adult rats to azoxymethane-induced aberrant crypt foci,” Cancer Letters, vol. 161, no. 2, pp. 185–193, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. R. P. Bird and C. K. Good, “The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer,” Toxicology Letters, vol. 112-113, pp. 395–402, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. R. P. Bird, “Role of aberrant crypt foci in understanding the pathogenesis of colon cancer,” Cancer Letters, vol. 93, no. 1, pp. 55–71, 1995. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Tanaka, “Colorectal carcinogenesis: review of human and experimental animal studies,” Journal of Carcinogenesis, vol. 8, article 5, 2009. View at Publisher · View at Google Scholar
  27. H. Mori, Y. Yamada, T. Kuno, and Y. Hirose, “Aberrant crypt foci and β-catenin accumulated crypts; significance and roles for colorectal carcinogenesis,” Mutation Research, vol. 566, no. 3, pp. 191–208, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. H. Mori, K. Hata, Y. Yamada, T. Kuno, and A. Hara, “Significance and role of early-lesions in experimental colorectal carcinogenesis,” Chemico-Biological Interactions, vol. 155, no. 1-2, pp. 1–9, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. G. P. Boivin, K. Washington, and K. Washington, “Pathology of mouse models of intestinal cancer: consensus report and recommendations,” Gastroenterology, vol. 124, no. 3, pp. 762–777, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. G. Caderni, A. P. Femia, A. Giannini, A. Favuzza, C. Luceri, M. Salvadori, and P. Dolara, “Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats: correlation with carcinogenesis,” Cancer Research, vol. 63, no. 10, pp. 2388–2392, 2003. View at Scopus
  31. R. P. Bird, “Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings,” Cancer Letters, vol. 37, no. 2, pp. 147–151, 1987. View at Scopus
  32. Q. Lu, BO. Jiang, C. Lin, and T. Shan, “Dark Aberrant Crypt Foci with activated Wnt pathway are related to tumorigenesis in the colon of AOM-treated rat,” Journal of Experimental and Clinical Cancer Research, vol. 27, no. 1, article 26, 2008. View at Publisher · View at Google Scholar · View at PubMed
  33. J. E. Paulsen, E. M. Løberg, H. B. Ølstørn, H. Knutsen, I. L. Steffensen, and J. Alexander, “Flat dysplastic aberrant crypt foci are related to tumorigenesis in the colon of azoxymethane-treated rat,” Cancer Research, vol. 65, no. 1, pp. 121–129, 2005. View at Scopus
  34. M. Ochiai, M. Watanabe, M. Nakanishi, A. Taguchi, T. Sugimura, and H. Nakagama, “Differential staining of dysplastic aberrant crypt foci in the colon facilitates prediction of carcinogenic potentials of chemicals in rats,” Cancer Letters, vol. 220, no. 1, pp. 67–74, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. Y. Yamada, N. Yoshimi, and N. Yoshimi, “Frequent β-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis,” Cancer Research, vol. 60, no. 13, pp. 3323–3327, 2000. View at Scopus
  36. T. P. Pretlow, B. J. Barrow, W. S. Ashton, M. A. O'Riordan, T. G. Pretlow, J. A. Jurcisek, and T. A. Stellato, “Aberrant crypts: putative preneoplastic foci in human colonic mucosa,” Cancer Research, vol. 51, no. 5, pp. 1564–1567, 1991. View at Scopus
  37. T. P. Pretlow and T. G. Pretlow, “Mutant KRAS in aberrant crypt foci (ACF): initiation of colorectal cancer?” Biochimica et Biophysica Acta, vol. 1756, no. 2, pp. 83–96, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. L. Cheng and M. D. Lai, “Aberrant crypt foci as microscopic precursors of colorectal cancer,” World Journal of Gastroenterology, vol. 9, no. 12, pp. 2642–2649, 2003. View at Scopus
  39. T. P. Pretlow, M. A. O'Riordan, K. M. Spancake, and T. G. Pretlow, “Two types of putative preneoplastic lesions identified by hexosaminidase activity in whole-mounts of colons from F344 rats treated with carcinogen,” American Journal of Pathology, vol. 142, no. 6, pp. 1695–1700, 1993. View at Scopus
  40. K. Otori, K. Sugiyama, T. Hasebe, S. Fukushima, and H. Esumi, “Emergence of adenomatous aberrant crypt foci (ACF) from hyperplastic ACF with concomitant increase in cell proliferation,” Cancer Research, vol. 55, no. 21, pp. 4743–4746, 1995. View at Scopus
  41. E. A. McLellan, A. Medline, and R. P. Bird, “Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions,” Cancer Research, vol. 51, no. 19, pp. 5270–5274, 1991. View at Scopus
  42. J. Raju, “Azoxymethane-induced rat aberrant crypt foci: relevance in studying chemoprevention of colon cancer,” World Journal of Gastroenterology, vol. 14, no. 43, pp. 6632–6635, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. H. S. Park, R. A. Goodlad, and N. A. Wright, “The incidence of aberrant crypt foci and colonic carcinoma in dimethylhydrazine-treated rats varies in a site-specific manner and depends on tumor histology,” Cancer Research, vol. 57, no. 20, pp. 4507–4510, 1997. View at Scopus
  44. M. A. M. Rodrigues, L. A. G. Silva, D. M. F. Salvadori, J. L. V. De Camargo, and M. R. Montenegro, “Aberrant crypt foci and colon cancer: comparison between a short-and medium-term bioassay for colon carcinogenesis using dimethylhydrazine in Wistar rats,” Brazilian Journal of Medical and Biological Research, vol. 35, no. 3, pp. 351–355, 2002. View at Scopus
  45. M. Ghirardi, R. Nascimbeni, V. Villanacci, M. G. Fontana, E. Di Betta, and B. Salerni, “Azoxymethane-induced aberrant crypt foci and colorectal tumors in F344 rats: sequential analysis of growth,” European Surgical Research, vol. 31, no. 3, pp. 272–280, 1999. View at Publisher · View at Google Scholar · View at Scopus
  46. A. P. Femia, B. Bendinelli, A. Giannini, M. Salvadori, P. Pinzani, P. Dolara, and G. Caderni, “Mucin-depleted foci have β-catenin gene mutations, altered expression of its protein, and are dose-and time-dependent in the colon of 1,2-dimethylhydrazine-treated rats,” International Journal of Cancer, vol. 116, no. 1, pp. 9–15, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. A. P. Femia, E. Tarquini, M. Salvadori, S. Ferri, A. Giannini, P. Dolara, and G. Caderni, “K-ras mutations and mucin profile in preneoplastic lesions and colon tumors induced in rats by 1,2-dimethylhydrazine,” International Journal of Cancer, vol. 122, no. 1, pp. 117–123, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. A. P. Femia, P. Dolara, A. Giannini, M. Salvadori, A. Biggeri, and G. Caderni, “Frequent mutation of Apc gene in rat colon tumors and mucin-depleted foci, preneoplastic lesions in experimental colon carcinogenesis,” Cancer Research, vol. 67, no. 2, pp. 445–449, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. A. P. Femia, P. Dolara, C. Luceri, M. Salvadori, and G. Caderni, “Mucin-depleted foci show strong activation of inflammatory markers in 1,2-dimethylhydrazine-induced carcinogenesis and are promoted by the inflammatory agent sodium dextran sulfate,” International Journal of Cancer, vol. 125, no. 3, pp. 541–547, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. A. Pietro Femia, P. Dolara, and G. Caderni, “Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomakers for colon carcinogenesis,” Carcinogenesis, vol. 25, no. 2, pp. 277–281, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. Y. Yamada, N. Yoshimi, and N. Yoshimi, “Sequential analysis of morphological and biological properties of β-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis,” Cancer Research, vol. 61, no. 5, pp. 1874–1878, 2001. View at Scopus
  52. N. Yoshimi, T. Morioka, and T. Morioka, “Histological and immunohistochemical observations of mucin-depleted foci (MDF) stained with Alcian blue, in rat colon carcinogenesis induced with 1,2-dimethylhydrazine dihydrochloride,” Cancer Science, vol. 95, no. 10, pp. 792–797, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. A. P. Femia, J. E. Paulsen, P. Dolara, J. Alexander, and G. Caderni, “Correspondence between flat aberrant crypt foci and mucin-depleted foci in rodent colon carcinogenesis,” Anticancer Research, vol. 28, no. 6 A, pp. 3771–3775, 2008. View at Scopus
  54. A. B. Sparks, P. J. Morin, B. Vogelstein, and K. W. Kinzler, “Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer,” Cancer Research, vol. 58, no. 6, pp. 1130–1134, 1998. View at Scopus
  55. R. P. Bird, D. Salo, C. Lasko, and C. Good, “A novel methodological approach to study the level of specific protein and gene expression in aberrant crypt foci putative preneoplastic colonic lesions by Western blotting and RT-PCR,” Cancer Letters, vol. 116, no. 1, pp. 15–19, 1997. View at Publisher · View at Google Scholar · View at Scopus
  56. C. Liu and J. Crawford, “The gastrointestinal tract,” in Robbins and Cotran Patologic Basis of Disease, V. Kumar, A. Abbas, and N. Fausto, Eds., pp. 797–875, Elsevier Saunders, 2004.
  57. P. J. Morin, A. B. Sparks, V. Korinek, N. Barker, H. Clevers, B. Vogelstein, and K. W. Kinzler, “Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC,” Science, vol. 275, no. 5307, pp. 1787–1790, 1997. View at Publisher · View at Google Scholar · View at Scopus
  58. C. De Filippo, G. Caderni, M. Bazzicalupo, C. Briani, A. Giannini, M. Fazi, and P. Dolara, “Mutations of the Apc gene in experimental colorectal carcinogenesis induced by azoxymethane in F344 rats,” British Journal of Cancer, vol. 77, no. 12, pp. 2148–2151, 1998. View at Scopus
  59. K. J. Sohn, M. Puchyr, and M. Puchyr, “The effect of dietary folate on Apc and p53 mutations in the dimethylhydrazine rat model of colorectal cancer,” Carcinogenesis, vol. 20, no. 12, pp. 2345–2350, 1999. View at Scopus
  60. C. A. Blum, T. Tanaka, and T. Tanaka, “Mutational analysis of Ctnnb1 and Apc in tumors from rats given 1,2-dimethylhydrazine or 2-amino-3-methylimidazo[4,5-f]quinoline: mutational 'hotspots' and the relative expression of β-catenin and c-jun,” Molecular Carcinogenesis, vol. 36, no. 4, pp. 195–203, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  61. A. P. Femia, C. Luceri, S. Toti, A. Giannini, P. Dolara, and G. Caderni, “Gene expression profile and genomic alterations in colonic tumours induced by 1,2-dimethylhydrazine (DMH) in rats,” BMC Cancer, vol. 10, article 194, 2010. View at Publisher · View at Google Scholar · View at PubMed
  62. M. Takahashi, M. Mutoh, T. Kawamori, T. Sugimura, and K. Wakabayashi, “Altered expression of β-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis,” Carcinogenesis, vol. 21, no. 7, pp. 1319–1327, 2000. View at Scopus
  63. M. Takahashi, K. Fukuda, T. Sugimura, and K. Wakabayashi, “β-catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors,” Cancer Research, vol. 58, no. 1, pp. 42–46, 1998. View at Scopus
  64. M. Hajdúch, S. Jančík, J. Drábek, and D. Radzioch, “Clinical relevance of KRAS in human cancers,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 150960, 2010. View at Publisher · View at Google Scholar · View at PubMed
  65. A. A. Vivona, B. Shpitz, and B. Shpitz, “K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis,” Carcinogenesis, vol. 14, no. 9, pp. 1777–1781, 1993. View at Scopus
  66. S. H. Erdman, H. D. Wu, L. J. Hixson, D. J. Ahnen, and E. W. Gerner, “Assessment of mutations in Ki-ras and p53 in colon cancers from azoxymethane- and dimethylhydrazine-treated rats,” Molecular Carcinogenesis, vol. 19, no. 2, pp. 137–144, 1997. View at Publisher · View at Google Scholar · View at Scopus
  67. C. Luceri, C. De Filippo, G. Caderni, L. Gambacciani, M. Salvadori, A. Giannini, and P. Dolara, “Detection of somatic DNA alterations in azoxymethane-induced F344 rat colon tumors by random amplified polymorphic DNA analysis,” Carcinogenesis, vol. 21, no. 9, pp. 1753–1756, 2000. View at Scopus
  68. M. Bissonnette, S. Khare, and S. Khare, “Mutational and nonmutational activation of p21 in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1,” Cancer Research, vol. 60, no. 16, pp. 4602–4609, 2000. View at Scopus
  69. R. F. Jacoby, X. Llor, B. B. Teng, N. O. Davidson, and T. A. Brasitus, “Mutations in the K-ras oncogene induced by 1,2-dimethylhydrazine in preneoplastic and neoplastic rat colonic mucosa,” Journal of Clinical Investigation, vol. 87, no. 2, pp. 624–630, 1991. View at Scopus
  70. S. A. Stopera, L. C. Murphy, and R. P. Bird, “Evidence for a ras gene mutation in azoxymethane-induced colonic aberrant crypts in Sprague-Dawley rats: earliest recognizable precursor lesions of experimental colon cancer,” Carcinogenesis, vol. 13, no. 11, pp. 2081–2085, 1992. View at Scopus
  71. M. Perse, V. Mlinaric, and A. Cerar, “Aberrant crypt foci as biomarkers predictive of colorectal carcinoma,” Slovenian Medical Journal, vol. 79, no. 6, pp. 499–506, 2010.
  72. N. Shivapurkar, K. J. Nikula, T. Tanaka, Z. C. Tang, and O. Alabaster, “Absence of p53 gene mutations in rat colon carcinomas induced through the synergistic interaction between methylazoxymethanol and X-irradiation,” Cancer Letters, vol. 113, no. 1-2, pp. 9–16, 1997. View at Publisher · View at Google Scholar · View at Scopus
  73. N. Shivapurkar, S. A. Belinsky, D. C. Wolf, Z. Tang, and O. Alabaster, “Absence of p53 gene mutations in rat colon carcinomas induced by azoxymethane,” Cancer Letters, vol. 96, no. 1, pp. 63–70, 1995. View at Publisher · View at Google Scholar · View at Scopus
  74. S. A. Stopera and R. P. Bird, “Immunohistochemical demonstration of mutant p53 tumour suppressor gene product in aberrant crypt foci,” Cytobios, vol. 73, no. 293, pp. 73–88, 1993. View at Scopus
  75. F. A. Orlando, D. Tan, and D. Tan, “Aberrant crypt foci as precursors in colorectal cancer progression,” Journal of Surgical Oncology, vol. 98, no. 3, pp. 207–213, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  76. M. Ravnik-Glavac, A. Cerar, and D. Glavac, “Animal model in the study of colorectal carcinogenesis,” Pflugers Archiv European Journal of Physiology, vol. 440, no. 5, pp. R55–R57, 2000. View at Scopus
  77. M. Takahashi, S. Nakatsugi, T. Sugimura, and K. Wakabayashi, “Frequent mutations of the β-catenin gene in mouse colon tumors induced by azoxymethane,” Carcinogenesis, vol. 21, no. 6, pp. 1117–1120, 2000. View at Scopus
  78. T. A. De Jong, S. A. Skinner, C. Malcontenti-Wilson, D. Vogiagis, M. Bailey, I. R. Van Driel, and P. E. O'Brien, “Inhibition of rat colon tumors by sulindac and sulindac sulfone is independent of K-ras (codon 12) mutation,” American Journal of Physiology - Gastrointestinal and Liver Physiology, vol. 278, no. 2, pp. G266–G272, 2000. View at Scopus
  79. Y. Kishimoto, T. Morisawa, A. Hosoda, G. Shiota, H. Kawasaki, and J. Hasegawa, “Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane,” Journal of Experimental and Clinical Cancer Research, vol. 21, no. 2, pp. 203–211, 2002. View at Scopus
  80. M. Bordonaro, “Modular Cre/lox system and genetic therapeutics for colorectal cancer,” Journal of Biomedicine and Biotechnology, vol. 2009, Article ID 358230, 2009. View at Publisher · View at Google Scholar · View at PubMed
  81. T. Jin, I. George Fantus, and J. Sun, “Wnt and beyond Wnt: multiple mechanisms control the transcriptional property of β-catenin,” Cellular Signalling, vol. 20, no. 10, pp. 1697–1704, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  82. F. T. Kolligs, G. Bommer, and B. Göke, “Wnt/beta-catenin/Tcf signaling: a critical pathway in gastrointestinal tumorigenesis,” Digestion, vol. 66, no. 3, pp. 131–144, 2002. View at Publisher · View at Google Scholar · View at Scopus
  83. . Xing Pei Hao, T. G. Pretlow, J. S. Rao, and T. P. Pretlow, “β-catenin expression is altered in human colonic aberrant crypt foci,” Cancer Research, vol. 61, no. 22, pp. 8085–8088, 2001. View at Scopus
  84. R. K. Wali, S. Khare, and S. Khare, “Ursodeoxycholic acid and F-D inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin,” Cancer Epidemiology Biomarkers and Prevention, vol. 11, no. 12, pp. 1653–1662, 2002. View at Scopus
  85. K. Otori, K. Sugiyama, S. Fukushima, and H. Esumi, “Expression of the cyclin D1 gene in rat colorectal aberrant crypt foci and tumors induced by azoxymethane,” Cancer Letters, vol. 140, no. 1-2, pp. 99–104, 1999. View at Publisher · View at Google Scholar · View at Scopus
  86. Y. Kishimoto, K. Yashima, T. Morisawa, G. Shiota, H. Kawasaki, and J. Hasegawa, “Effects of cyclooxygenase-2 inhibitor NS-398 on APC and c-myc expression in rat colon carcinogenesis induced by azoxymethane,” Journal of Gastroenterology, vol. 37, no. 3, pp. 186–193, 2002. View at Publisher · View at Google Scholar · View at Scopus
  87. O. Takayama, H. Yamamoto, and H. Yamamoto, “Expression of PPARδ in multistage carcinogenesis of the colorectum: implications of malignant cancer morphology,” British Journal of Cancer, vol. 95, no. 7, pp. 889–895, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  88. H. K. Roy, W. J. Karolski, and A. Ratashak, “Distal bowel selectivity in the chemoprevention of experimental colon carcinogenesis by the non-steroidal anti-inflammatory drug nabumetone,” International Journal of Cancer, vol. 92, no. 4, pp. 609–615, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  89. H. K. Roy, B. F. Olusola, D. L. Clemens, W. J. Karolski, A. Ratashak, H. T. Lynch, and T. C. Smyrk, “AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis,” Carcinogenesis, vol. 23, no. 1, pp. 201–205, 2002. View at Scopus
  90. I. Thorup, “Histomorphological and immunohistochemical characterization of colonic aberrant crypt foci in rats: relationship to growth factor expression,” Carcinogenesis, vol. 18, no. 3, pp. 465–472, 1997. View at Publisher · View at Google Scholar · View at Scopus
  91. J. Shao, H. Sheng, and H. Sheng, “Coordinate regulation of cyclooxygenase-2 and TGF-β1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors,” Carcinogenesis, vol. 20, no. 2, pp. 185–191, 1999. View at Publisher · View at Google Scholar · View at Scopus
  92. J. Massagué, “TGFβ in Cancer,” Cell, vol. 134, no. 2, pp. 215–230, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  93. E. Spisni, A. Strillacci, C. Griffoni, M. C. Valerii, G. Lazzarini, and V. Tomasi, “RNAi-based strategies for cyclooxygenase-2 inhibition in cancer,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 828045, 2010. View at Publisher · View at Google Scholar · View at PubMed
  94. R. N. DuBois, A. Radhika, B. S. Reddy, and A. J. Entingh, “Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors,” Gastroenterology, vol. 110, no. 4, pp. 1259–1262, 1996. View at Publisher · View at Google Scholar · View at Scopus
  95. M. Perše, A. Zebic, and A. Cerar, “Rofecoxib does not inhibit aberrant crypt foci formation but inhibits later steps in the development of experimental colorectal cancer: rofecoxib in experimental colon cancer,” Scandinavian Journal of Gastroenterology, vol. 40, no. 1, pp. 61–67, 2005. View at Publisher · View at Google Scholar · View at Scopus
  96. T. Kawamori, M. Takahashi, K. Watanabe, T. Ohta, S. Nakatsugi, T. Sugimura, and K. Wakabayashi, “Suppression of azoxymethane-induced colonic aberrant crypt foci by a nitric oxide synthase inhibitor,” Cancer Letters, vol. 148, no. 1, pp. 33–37, 2000. View at Publisher · View at Google Scholar · View at Scopus
  97. K. E. Kearney, T. G. Pretlow, and T. P. Pretlow, “Increased expression of fatty acid synthase in human aberrant crypt foci: possible target for colorectal cancer prevention,” International Journal of Cancer, vol. 125, no. 1, pp. 249–252, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  98. D. S. Y. Lau and M. C. Archer, “Fatty acid synthase is over-expressed in large aberrant crypt foci in rats treated with azoxymethane,” International Journal of Cancer, vol. 124, no. 11, pp. 2750–2753, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  99. R. Marzocchini, F. Malentacchi, M. Biagini, D. Cirelli, C. Luceri, G. Caderni, and G. Raugei, “The expression of low molecular weight protein tyrosine phosphatase is up-regulated in 1,2-dimethylhydrazine-induced colon tumours in rats,” International Journal of Cancer, vol. 122, no. 7, pp. 1675–1678, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  100. T. Devasena, V. P. Menon, and K. N. Rajasekharan, “Prevention of 1,2-dimethylhydrazine-induced circulatory oxidative stress by bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione during colon carcinogenesis,” Pharmacological Reports, vol. 58, no. 2, pp. 229–235, 2006. View at Scopus
  101. M. Perše, R. Injac, B. Štrukelj, and A. Cerar, “Effects of high-fat mixed-lipid diet and exercise on the antioxidant system in skeletal and cardiac muscles of rats with colon carcinoma,” Pharmacological Reports, vol. 61, no. 5, pp. 909–916, 2009. View at Scopus
  102. R. Injac, M. Perse, and M. Perse, “Protective effects of fullerenol C(OH) against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer,” Biomaterials, vol. 30, no. 6, pp. 1184–1196, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  103. V. Sreedharan, K. K. Venkatachalam, and N. Namasivayam, “Effect of morin on tissue lipid peroxidation and antioxidant status in 1, 2-dimethylhydrazine induced experimental colon carcinogenesis,” Investigational New Drugs, vol. 27, no. 1, pp. 21–30, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  104. J. S. Giftson, S. Jayanthi, and N. Nalini, “Chemopreventive efficacy of gallic acid, an antioxidant and anticarcinogenic polyphenol, against 1,2-dimethyl hydrazine induced rat colon carcinogenesis,” Investigational New Drugs, vol. 28, no. 3, pp. 251–259, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  105. V. Manju, V. Balasubramaniyan, and N. Nalini, “Rat colonic lipid peroxidation and antioxidant status: the effects of dietary luteolin on 1,2-dimethylhydrazine challenge,” Cellular and Molecular Biology Letters, vol. 10, no. 3, pp. 535–551, 2005. View at Scopus
  106. S. Samanta, V. Swamy, D. Suresh, M. Rajkumar, B. Rana, A. Rana, and M. Chatterjee, “Protective effects of vanadium against DMH-induced genotoxicity and carcinogenesis in rat colon: removal of O-methylguanine DNA adducts, p53 expression, inducible nitric oxide synthase downregulation and apoptotic induction,” Mutation Research, vol. 650, no. 2, pp. 123–131, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  107. J. P. Sunter, D. R. Appleton, N. A. Wright, and A. J. Watson, “Pathological features of the colonic tumours induced in rats by the administration of 1,2-dimethylhydrazine,” Virchows Archiv B Cell Pathology, vol. 29, no. 1, pp. 211–223, 1978. View at Publisher · View at Google Scholar · View at Scopus
  108. T. J. McGarrity, L. P. Peiffer, and P. C. Colony, “Cellular proliferation in proximal and distal rat colon during 1,2-dimethylhydrazine-induced carcinogenesis,” Gastroenterology, vol. 95, no. 2, pp. 343–348, 1988. View at Scopus
  109. M. Gamberini, M. R. Cidade, L. A. Valotta, M. C. S. Armelin, and L. C. C. Leite, “Contribution of hydrazines-derived alkyl radicals to cytotoxicity and transformation induced in normal c-myc-overexpressing mouse fibroblasts,” Carcinogenesis, vol. 19, no. 1, pp. 147–155, 1998. View at Publisher · View at Google Scholar · View at Scopus
  110. J. Hau, “Animal models,” in Handbook of Laboratory Animal Sience: Animal Models, J. Hau and G. van Hoosier, Eds., pp. 1–9, CRC Press, Boca Raton, Fla, USA, 2003.
  111. O. S. Sohn, E. S. Fiala, S. P. Requeijo, J. H. Weisburger, and F. J. Gonzalez, “Differential effects of CYP2E1 status on the metabolic activation of the colon carcinogens azoxymethane and methylazoxymethanol,” Cancer Research, vol. 61, no. 23, pp. 8435–8440, 2001. View at Scopus
  112. M. Perše and A. Cerar, “Dimethylhydrazine model is not appropriate for evaluating effect of ethanol on colorectal cancer,” Revista Espanola de Enfermedades Digestivas, vol. 99, no. 8, pp. 463–466, 2007. View at Scopus
  113. J. F. Noguera Aguilar and A. Cuadrado García, “Ethanol and colic experimental carcinogenesisEtanol y carcinogénesis cólica experimental,” Revista Espanola de Enfermedades Digestivas, vol. 99, no. 8, pp. 438–439, 2007. View at Scopus